Atlas Trials

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Clinical trial NCT00830973 · COMPLETED

Trial details

NCT number
NCT00830973
Sponsor
Medco Health Solutions, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Breast NeoplasmsTamoxifen
Start date
2007-10-01
Primary completion
2008-12-01
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.